Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Abcellera Biologics Inc (ABCL)

137 + Investors. Track Smart Money conviction in ABCL. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -7
Streak
2Q ▼
Buyers last Q
55%

Smart Money Signals — ABCL

Based on 137 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their ABCL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 87% of 3.0Y peak

87% of all-time peak
137 funds currently hold this stock — 87% of the 3.0-year high of 158 funds (reached 2023 Q2). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +7% more funds vs a year ago

fund count last 6Q
+9 new funds entered over the past year (+7% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 55% buying

76 buying62 selling
Last quarter: 76 funds bought or added vs 62 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-8 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 21 → 38 → 28 → 20. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 24% medium ■ 20% new
76 out of 137 hedge funds have held ABCL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📊

Peak discovery — momentum slowing

13 → 21 → 38 → 28 → 20 new funds/Q
New funds entering each quarter: 21 → 38 → 28 → 20. ABCL is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 63% veterans vs 22% newcomers

■ 63% veterans ■ 15% 1-2yr ■ 22% new
Entry-cohort mix of 150 holders: 95 (63%) are 2+ year veterans, 22 entered 1–2 years ago, and 33 (22%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 32% AUM from major funds

32% from top-100 AUM funds
28 of 136 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.0
out of 10
Low Exit Risk
Exit risk score 3.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ABCL

In 2026 Q1, 76 hedge funds were net buyers of ABCL (20 opened a new position, 56 added to an existing one), while 62 reduced or exited (35 trimmed, 27 sold completely) — a 55% buyer ratio, indicating a slight buying edge. Net selling has persisted for two consecutive quarters. 32% of total institutional value in ABCL is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: -7 funds (more exits than new entries). Total institutional holders: 137.

Hedge Fund Ownership: ABCL

How many hedge funds hold ABCL — quarterly history vs. share price
Quarterly hedge fund ownership of ABCL vs. share price

Market Analysis: ABCL

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ABCL

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Abcellera Biologics Inc (ABCL) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ABCL has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
ABCL
+55.9%
XLV
+2.8%

ABCL outperformed XLV by +53.1% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
ABCL
+33.0%
XLV
+3.9%

Since the filing became public, ABCL outperformed XLV by +29.1% .

Interpretation: The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 0 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
0.4
/ 10
conviction
Hedge Fund Positioning: ABCL
137 + Investors

Track Smart Money conviction in ABCL. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 137 144 -4.86%
13F Shares 134M 110M 21.78%
Total Value $468M $376M 24.25%
New Positions 20 28 -8
Increased Positions 53 52 +1
Closed Positions 27 30 -3
Reduced Positions 34 39 -5
Total Calls 8 6 33.33%
Total Puts 6 5 20.0%
PUT/CALL Ratio 0.75 0.83 Neutral

Statistics: ABCL

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

137 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ABCL. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ABCL holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Baker BROS. Advisors LP 0.61% 30,275,938 $105.7M
2 Guardian Partners Inc. 0.52% 1,786,415 $6.3M
3 Intellectus Partners, LLC 0.39% 546,083 $1.9M
4 ArrowMark Colorado Holdings LLC 0.38% 4,105,095 $14.3M
5 Ground Swell Capital, LLC 0.11% 15,820 $55K
6 Pier 88 Investment Partners LLC 0.10% 120,100 $419K
7 Driehaus Capital Management LLC 0.10% 4,024,779 $14.0M
8 TD Waterhouse Canada Inc. 0.10% 9,564,659 $33.6M
9 ArchPoint Investors 0.10% 115,055 $402K
10 Resolute Advisors LLC 0.08% 57,526 $201K
11 Green Alpha Advisors, LLC 0.08% 22,944 $80K
12 Headlands Technologies LLC 0.07% 182,656 $637K
13 Virtus Investment Advisers, LLC 0.07% 75,327 $263K
14 Jefferies Financial Group Inc. 0.07% 2,746,200 $9.6M
15 Jefferies Financial Group Inc. 0.07% 2,736,200 $9.5M
16 Axq Capital, LP 0.06% 136,227 $475K
17 Brandywine Managers, LLC 0.06% 28,488 $99K
18 MOR Wealth Management, LLC 0.05% 33,000 $115K
19 Intesa Sanpaolo S.p.A. 0.03% 164,371 $567K
20 Two Sigma Advisers, LP 0.03% 4,878,000 $16.7M
21 Two Sigma Investments, LP 0.03% 10,562,065 $36.9M
22 Alyeska Investment Group, L.P. 0.03% 2,592,105 $9.0M
23 DKM Wealth Management, Inc. 0.03% 10,000 $35K
24 Lantern Wealth Advisors, LLC 0.02% 10,000 $35K
25 Integrity Financial Corp /WA 0.02% 10,000 $35K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Abcellera Biologics Inc (ABCL)

What does the Smart Money Trend signal show for ABCL?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their ABCL positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ABCL?

Slight buying edge — 55% buying: Last quarter: 76 funds bought or added vs 62 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ABCL holders?

Strong quality — 32% AUM from major funds: 28 of 136 holders rank in the top 100 by AUM, accounting for 32% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ABCL?

55% of holders stayed for 2+ years: 76 out of 137 hedge funds have held ABCL for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Abcellera Biologics Inc (ABCL) following the 2026 Q1 hedge fund 13F filings?

As of today, ABCL has moved +33.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.9% for the XLV sector ETF — an outperformance of +29.1%. Since the quarter end (March 31, 2026), ABCL has gained +55.9% vs +2.8% for XLV. The stock has significantly outperformed its sector benchmark — the original entry opportunity has largely been captured by earlier investors.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →